The influence of opioids on matrix metalloproteinase-2 and-9 secretion and mRNA levels in MCF-7 breast cancer cell line

被引:44
作者
Gach, Katarzyna [1 ]
Szemraj, Janusz [2 ]
Wyrebska, Anna [1 ]
Janecka, Anna [1 ]
机构
[1] Med Univ Lodz, Dept Biomol Chem, PL-92215 Lodz, Poland
[2] Med Univ Lodz, Dept Biochem, PL-92215 Lodz, Poland
关键词
Nitric oxide synthase; Biochemical markers; ELISA assay; RT-PCR; NITRIC-OXIDE; GENE-EXPRESSION; MATRIX-METALLOPROTEINASE-2; MECHANISMS;
D O I
10.1007/s11033-010-0222-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Matrix metalloproteinases (MMPs) are proteolytic enzymes involved in degradation of extracellular matrix, a process that initiates uncontrolled spread of proliferating cancer cells and therefore plays a crucial role in cancer invasion and metastasis. Compounds able to modulate MMP activity may become important tools in cancer research. In the present study we examined the effect of two mu-selective opioids, morphine and endomorphin-2 (EM-2) on the production of MMP-2 and MMP-9 in MCF-7 cells. We report that both opioids time- and concentration-dependently inhibited the expression and secretion of these MMPs. The observed effect was not reversed by naloxone (Nal). Further experiments showed that morphine and EM-2 decreased endothelial nitric oxide synthase (eNOS) mRNA level and nitric oxide (NO) secretion in MCF-7 cells. These findings indicate that attenuation of MMP secretion by opioids was not mediated by opioid receptors but was under the control of nitric oxide system.
引用
收藏
页码:1231 / 1236
页数:6
相关论文
共 23 条
[1]   Regulation of matrix metalloproteinases: An overview [J].
Chakraborti, S ;
Mandal, M ;
Das, S ;
Mandal, A ;
Chakraborti, T .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2003, 253 (1-2) :269-285
[2]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[3]   The basement membrane matrix in malignancy [J].
Engbring, JA ;
Kleinman, HK .
JOURNAL OF PATHOLOGY, 2003, 200 (04) :465-470
[4]   Synthesis and characterization of potent and selective μ-opioid receptor antagonists, [Dmt1, D-2-Nal4]endomorphin-1 (antanal-1) and [Dmt1, D-2-Nal4]endomorphin-2 (antanal-2) [J].
Fichna, Jakub ;
do-Rego, Jean-Claude ;
Chung, Nga N. ;
Lemieux, Carole ;
Schiller, Peter W. ;
Poels, Jeroen ;
Broeck, Jozef Vanden ;
Costentin, Jean ;
Janecka, Anna .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (03) :512-520
[5]  
Gach K, 2008, BIOCHEM CELL BIOL, V86, P217, DOI [10.1139/O08-001, 10.1139/o08-001]
[6]   Potential ability of morphine to inhibit the adhesion, invasion and metastasis of metastatic colon 26-L5 carcinoma cells [J].
Harimaya, Y ;
Koizumi, K ;
Andoh, T ;
Nojima, H ;
Kuraishi, Y ;
Saiki, I .
CANCER LETTERS, 2002, 187 (1-2) :121-127
[7]   Opioid-somatostatin interactions in regulating cancer cell growth [J].
Hatzoglou, A ;
Kampa, M ;
Castanas, E .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2005, 10 :244-256
[8]   Effects of nitric oxide on matrix metalloproteinase-2 production by rheumatoid synovial cells [J].
Hirai, Y ;
Migita, K ;
Honda, S ;
Ueki, Y ;
Yamasaki, S ;
Urayama, S ;
Kamachi, M ;
Kawakami, A ;
Ida, H ;
Kita, M ;
Fukuda, T ;
Shibatomi, K ;
Kawabe, Y ;
Aoyagi, T ;
Eguchi, K .
LIFE SCIENCES, 2001, 68 (08) :913-920
[9]   Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145) through a partial interaction with opioid receptors [J].
Kampa, M ;
Bakogeorgou, E ;
Hatzoglou, A ;
Damianaki, A ;
Martin, PM ;
Castanas, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 335 (2-3) :255-265
[10]   Opioids are non-competitive inhibitors of nitric oxide synthase in T47D human breast cancer cells [J].
Kampa, M ;
Hatzoglou, A ;
Notas, G ;
Niniraki, M ;
Kouroumalis, E ;
Castanas, E .
CELL DEATH AND DIFFERENTIATION, 2001, 8 (09) :943-952